Critical Path Institute’s® Translational Therapeutics Accelerator today officially launched its 2026 global Request for Proposals for Bridging Research and Innovation in Drug Development Grants. These ...
TUCSON, Ariz., July 22, 2025 — Stakeholders across the life sciences ecosystem are invited to attend the 2025 Critical Path Institute® (C-Path) Global Impact Conference (CGIC), taking place Sept. 9–11 ...
Critical Path Institute’s Translational Therapeutics Accelerator has invested in the development of QED-203 for advanced and therapy-resistant prostate cancer. Based on research at the University of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback